149 related articles for article (PubMed ID: 12691468)
1. New therapies on the horizon for hepatitis C: are we close?
De Francesco R; Rice CM
Clin Liver Dis; 2003 Feb; 7(1):211-42, xi. PubMed ID: 12691468
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C: therapeutic perspectives.
Cornberg M; Wedemeyer H; Manns MP
Forum (Genova); 2001; 11(2):154-62. PubMed ID: 11948360
[TBL] [Abstract][Full Text] [Related]
3. New drugs for hepatitis C virus (HCV).
Clarke BE
Baillieres Best Pract Res Clin Gastroenterol; 2000 Apr; 14(2):293-305. PubMed ID: 10890323
[TBL] [Abstract][Full Text] [Related]
4. Current and evolving therapies for hepatitis C.
Moradpour D; Blum HE
Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1199-202. PubMed ID: 10563526
[TBL] [Abstract][Full Text] [Related]
5. Modulation of host metabolism as a target of new antivirals.
Ikeda M; Kato N
Adv Drug Deliv Rev; 2007 Oct; 59(12):1277-89. PubMed ID: 17897752
[TBL] [Abstract][Full Text] [Related]
6. [Experimental therapy in HCV infection].
Inglot M; Gładysz A; Rymer W
Przegl Epidemiol; 2005; 59(2):525-33. PubMed ID: 16190563
[TBL] [Abstract][Full Text] [Related]
7. Future trends in managing hepatitis C.
McHutchison JG; Dev AT
Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S51-61. PubMed ID: 15081103
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of hepatitis C virus inhibitors.
Smith RM; Wu GY
J Viral Hepat; 2003 Nov; 10(6):405-12. PubMed ID: 14633172
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus therapies: current treatments, targets and future perspectives.
Walker MP; Appleby TC; Zhong W; Lau JY; Hong Z
Antivir Chem Chemother; 2003 Jan; 14(1):1-21. PubMed ID: 12790512
[TBL] [Abstract][Full Text] [Related]
10. Evaluation systems for anti-HCV drugs.
Moriishi K; Matsuura Y
Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
[TBL] [Abstract][Full Text] [Related]
11. Future therapies for hepatitis C.
Pawlotsky JM; Gish RG
Antivir Ther; 2006; 11(4):397-408. PubMed ID: 16856613
[TBL] [Abstract][Full Text] [Related]
12. Advances in hepatitis C: what is coming in the next 5 years?
Locarnini SA; Bartholomeusz A
J Gastroenterol Hepatol; 2002 Apr; 17(4):442-7. PubMed ID: 11982725
[TBL] [Abstract][Full Text] [Related]
13. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
Suzuki T
Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
[TBL] [Abstract][Full Text] [Related]
14. New HCV therapies on the horizon.
Vermehren J; Sarrazin C
Clin Microbiol Infect; 2011 Feb; 17(2):122-34. PubMed ID: 21087349
[TBL] [Abstract][Full Text] [Related]
15. Promising candidates for the treatment of chronic hepatitis C.
Walker MP; Yao N; Hong Z
Expert Opin Investig Drugs; 2003 Aug; 12(8):1269-80. PubMed ID: 12882616
[TBL] [Abstract][Full Text] [Related]
16. Future options for the management of hepatitis C.
Davis GL; Nelson DR; Reyes GR
Semin Liver Dis; 1999; 19 Suppl 1():103-12. PubMed ID: 10349698
[TBL] [Abstract][Full Text] [Related]
17. Anti-hepatitis C virus RdRp activity and replication of novel anilinobenzothiazole derivatives.
Peng HK; Chen WC; Lin YT; Tseng CK; Yang SY; Tzeng CC; Lee JC; Yang SC
Antiviral Res; 2013 Oct; 100(1):269-75. PubMed ID: 23994188
[TBL] [Abstract][Full Text] [Related]
18. Prospects for nucleic acid-based therapeutics against hepatitis C virus.
Lee CH; Kim JH; Lee SW
World J Gastroenterol; 2013 Dec; 19(47):8949-62. PubMed ID: 24379620
[TBL] [Abstract][Full Text] [Related]
19. Investigational drugs for hepatitis C.
Flisiak R; Parfieniuk A
Expert Opin Investig Drugs; 2010 Jan; 19(1):63-75. PubMed ID: 20001555
[TBL] [Abstract][Full Text] [Related]
20. Dynamic evolution of therapy for chronic hepatitis C: how will novel agents be incorporated into the standard of care?
Zeuzem S; Nelson DR; Marcellin P
Antivir Ther; 2008; 13(6):747-60. PubMed ID: 18839776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
